Literature DB >> 2960708

Azaspirodecanediones in generalized anxiety disorder: buspirone.

A Ortiz1, R Pohl, S Gershon.   

Abstract

Buspirone is a new anxiolytic that is structurally unrelated to other psychotropic drugs. The drug is as effective as benzodiazepines for the treatment of generalized anxiety, and superior to placebo. The effect of buspirone on other anxiety disorders, such as panic disorder or post-traumatic stress disorder, remains untested. Although buspirone's mechanism of action is unknown, it clearly does not act on the same receptor systems that are affected by benzodiazepines. Buspirone appears to lack dependence and abuse potential and has little or no sedative effect. In addition, the drug does not potentiate sedative-hypnotic drugs and does not potentiate functional impairment produced by alcohol. Like benzodiazepines, buspirone appears to be safe even when given in very high doses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960708     DOI: 10.1016/0165-0327(87)90018-8

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

1.  Buspirone impairment of performance of passive avoidance and spatial learning tasks in the rat.

Authors:  M J Rowan; W K Cullen; B Moulton
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  TJS-010, a new prescription of oriental medicine, enhances 8-OH-DPAT-induced effects in rats.

Authors:  A Kagaya; A J Tanra; H Shinno; A Kugaya; M Muraoka; T Oyamada; Y Uchitomi; S Yamawaki
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple doses.

Authors:  R H Barbhaiya; U A Shukla; M Pfeffer; K A Pittman; R Shrotriya; C Laroudie; R E Gammans
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.